Tesamorelin

Tesamorelin is a synthetic peptide, specifically a growth hormone-releasing hormone (GHRH) analogue, approved by the FDA to reduce excess abdominal (visceral) fat in HIV-positive patients with lipodystrophy. It works by stimulating natural growth hormone release, offering benefits like improved body composition, reduced fat, and potential anti-inflammatory effects.

• Treatment for HIV-associated lipodystrophy to reduce visceral belly fat.

• It acts as a growth hormone-releasing factor (GRF) analog, increasing natural GH levels.

• Tesamorelin acetate 

• TH9507 

• There are no long-term human studies, and these peptides are not approved by the FDA, with potential risks unknown.

• They are often sourced through specialized, clinician-guided, or anti-aging, clinics.